5-(2,3-dimethylimidazol-4-yl)-3-[4-(furan-3-yl)-1H-pyrrolo[2,3-b]pyridin-2-yl]-1H-pyrazolo[4,3-b]pyridine
C22H17N7O — CID 137038483
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-(2,3-dimethylimidazol-4-yl)-3-[4-(furan-3-yl)-1H-pyrrolo[2,3-b]pyridin-2-yl]-1H-pyrazolo[4,3-b]pyridine
5-(2,3-dimethylimidazol-4-yl)-3-[4-(furan-3-yl)-1H-pyrrolo[2,3-b]pyridin-2-yl]-1H-pyrazolo[4,3-b]pyridine (PubChem CID 137038483) has the molecular formula C22H17N7O and a molecular weight of 395.43 g/mol. Its IUPAC name is 5-(2,3-dimethylimidazol-4-yl)-3-[4-(furan-3-yl)-1H-pyrrolo[2,3-b]pyridin-2-yl]-1H-pyrazolo[4,3-b]pyridine.
Molecular Properties
| Compound Name | 5-(2,3-dimethylimidazol-4-yl)-3-[4-(furan-3-yl)-1H-pyrrolo[2,3-b]pyridin-2-yl]-1H-pyrazolo[4,3-b]pyridine |
|---|---|
| PubChem CID | 137038483 |
| Molecular Formula | C22H17N7O |
| Molecular Weight | 395.43 g/mol |
| Exact Mass | 395.15 |
| IUPAC Name | 5-(2,3-dimethylimidazol-4-yl)-3-[4-(furan-3-yl)-1H-pyrrolo[2,3-b]pyridin-2-yl]-1H-pyrazolo[4,3-b]pyridine |
| SMILES | Cc1ncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccoc6)ccnc5[nH]4)c3n2)n1C |
| InChI | InChI=1S/C22H17N7O/c1-12-24-10-19(29(12)2)16-3-4-17-20(25-16)21(28-27-17)18-9-15-14(13-6-8-30-11-13)5-7-23-22(15)26-18/h3-11H,1-2H3,(H,23,26)(H,27,28) |
| InChIKey | MBDHGXLZKJTFOB-UHFFFAOYSA-N |
| XLogP | 4.47 |
| TPSA | 101.21 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 395.43 |
| LogP ≤ 5 | 4.47 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 137038483 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.